200 related articles for article (PubMed ID: 31801358)
21. Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
Dai X; Liu D; Liu M; Zhang X; Wang W; Jin F; Qian Y; Wang X; Zhao J; Wu Y; Xiong F; Chang NA; Sun YU; Yang Z; Hoffman RM; Liu Y
Anticancer Res; 2017 Mar; 37(3):979-986. PubMed ID: 28314255
[No Abstract] [Full Text] [Related]
22. The anticancer effect of Huaier (Review).
Song X; Li Y; Zhang H; Yang Q
Oncol Rep; 2015 Jul; 34(1):12-21. PubMed ID: 25955759
[TBL] [Abstract][Full Text] [Related]
23. Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants.
Chang R
J Altern Complement Med; 2002 Oct; 8(5):559-65. PubMed ID: 12470436
[TBL] [Abstract][Full Text] [Related]
24. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention.
Wang D; Wang F; Kong X; Li Q; Shi H; Zhao S; Li W; Li Y; Meng J
Biomed Pharmacother; 2022 Sep; 153():113376. PubMed ID: 36076519
[TBL] [Abstract][Full Text] [Related]
25. [Current topics on cancer biology and research strategies for anti-cancer traditional Chinese medicine].
Chen XP; Tang ZH; Shi Z; Lu JJ; Su HX; Chen X; Wang YT
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3416-22. PubMed ID: 26978983
[TBL] [Abstract][Full Text] [Related]
26. Three advantages of using traditional Chinese medicine to prevent and treat tumor.
Ling CQ; Yue XQ; Ling C
J Integr Med; 2014 Jul; 12(4):331-5. PubMed ID: 25074882
[TBL] [Abstract][Full Text] [Related]
27. [Molecular mechanisms of non-coding RNA regulating autophagy and interventional effects of Chinese herbal medicine].
Tu Y; Wan YG; Gu YH; Liu BH; Liu YL; Wang WW; Fang QJ; Yee HY; Wu W; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4545-4551. PubMed ID: 31872646
[TBL] [Abstract][Full Text] [Related]
28. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.
Guo G; Zhou J; Yang X; Feng J; Shao Y; Jia T; Huang Q; Li Y; Zhong Y; Nagarkatti PS; Nagarkatti M
Integr Cancer Ther; 2018 Dec; 17(4):1059-1067. PubMed ID: 30343602
[TBL] [Abstract][Full Text] [Related]
29. Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs.
Wang X; Xu L; Lao Y; Zhang H; Xu H
Curr Protein Pept Sci; 2018 Feb; 19(4):380-388. PubMed ID: 28059040
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targets of Traditional Chinese Medicine for colorectal cancer.
Li W; Li C; Zheng H; Chen G; Hua B
J Tradit Chin Med; 2016 Apr; 36(2):243-9. PubMed ID: 27400481
[TBL] [Abstract][Full Text] [Related]
31. Progresses in TCM metal-based antitumour agents.
Chen ZF; Liang H
Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
[TBL] [Abstract][Full Text] [Related]
32. [Review on experimental research of Chinese herbal medicine and its components intervention for tumor metastasis].
Wang XF; Su SB
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2583-7. PubMed ID: 19216146
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.
Xu H; Zhao X; Liu X; Xu P; Zhang K; Lin X
Drug Des Devel Ther; 2015; 9():2735-44. PubMed ID: 26056434
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs affect tumor metastasis through regulating epithelial- mesenchymal transition.
Yang L; Shen X; Li J; Yang J; Le Y; Gong Z
Yi Chuan; 2014 Jul; 36(7):637-45. PubMed ID: 25076027
[TBL] [Abstract][Full Text] [Related]
35. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
Peng F; Xiong L; Tang H; Peng C; Chen J
Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
[TBL] [Abstract][Full Text] [Related]
36. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
[TBL] [Abstract][Full Text] [Related]
37. Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.
Zhang J; Li X; Huang L
Adv Drug Deliv Rev; 2020; 154-155():245-273. PubMed ID: 32473991
[TBL] [Abstract][Full Text] [Related]
38. Use of compound Chinese medicine in the treatment of lung cancer.
Tian G; Guo L; Gao W
Curr Drug Discov Technol; 2010 Mar; 7(1):32-6. PubMed ID: 20156141
[TBL] [Abstract][Full Text] [Related]
39. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
[TBL] [Abstract][Full Text] [Related]
40. Oral traditional Chinese medication for adhesive small bowel obstruction.
Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
